image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

ImmuPharma

April 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • IMM
  • Price:
  • 136.5p
I met ImmuPharma during the month. The company’s contract research organisation, Simbec Orion, has spent the past few weeks cleaning up the data collected from all 200 patients on the Lupuzor phase 3 trial, ensuring each bit of data is recorded correctly (eg. a ‘5’ isn’t recorded as a ‘3’). The database will be locked on 6 April, at which point it will be unblinded so that  analysis can be carried out with the top line results the following week. By next month IMM will be anywhere from 30p to 500p+ depending on the outcome, hopefully the latter as earlier trial data was good and the safety profile excellent. It’s also appointed a European M&A specialist so a bid at a multiple of the pric ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

ImmuPharma (May 2018)
Immupharma (February 2018)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW